TY - JOUR AU - Humeniuk, Michael S. AU - Kelley, Michael John PY - 2016 TI - Second line treatment of small cell lung cancer: more is better? JF - Annals of Translational Medicine; Vol 4, Supplement 1 (October 31, 2016): Annals of Translational Medicine Y2 - 2016 KW - N2 - Extensive stage small cell lung cancer (SCLC) is an aggressive disease that leaves less than 10% of patients alive at 2 years (1). UR - https://atm.amegroups.org/article/view/12254